Pharsight

Phathom patents expiration

1. Voquezna Dual Pak patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7977488 PHATHOM 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
Aug, 2028

(4 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9186411 PHATHOM Pharmaceutical composition
Aug, 2030

(6 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) May 3, 2027
Generating Antibiotic Incentives Now (GAIN) May 3, 2032

Drugs and Companies using AMOXICILLIN; VONOPRAZAN FUMARATE ingredient

NCE-1 date: 2031-05-04

Market Authorisation Date: 03 May, 2022

Treatment: NA

Dosage: CAPSULE, TABLET;ORAL

More Information on Dosage

VOQUEZNA DUAL PAK family patents

Family Patents

2. Voquezna Triple Pak patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7977488 PHATHOM 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
Aug, 2028

(4 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9186411 PHATHOM Pharmaceutical composition
Aug, 2030

(6 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) May 3, 2027
Generating Antibiotic Incentives Now (GAIN) May 3, 2032

Drugs and Companies using AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE ingredient

NCE-1 date: 2031-05-04

Market Authorisation Date: 03 May, 2022

Treatment: NA

Dosage: CAPSULE, TABLET, TABLET;ORAL

More Information on Dosage

VOQUEZNA TRIPLE PAK family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic